Explore more publications!
Health Wire Syria
Submit Press Release

Health Wire Syria: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Syria.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 18, 2025

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
November 18, 2025

Clearmind Medicine Announces Positive Top-Line Results from First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Indeterminate GlobeNewswire
AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program
November 18, 2025

AIM ImmunoTech Reports Third Quarter 2025 Financial Results and Highlights Continued Progress Across Pipeline with Strategic Focus on Pancreatic Cancer Clinical Program

Indeterminate GlobeNewswire
Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer
November 18, 2025

Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer

Indeterminate GlobeNewswire
InStride Health Data Reveal 80% of Caregivers Report Reduction in Caregiver Strain among Families Navigating Youth Anxiety and OCD
November 18, 2025

InStride Health Data Reveal 80% of Caregivers Report Reduction in Caregiver Strain among Families Navigating Youth Anxiety and OCD

Indeterminate GlobeNewswire
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
November 18, 2025

Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada

Indeterminate GlobeNewswire
Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules
November 18, 2025

Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules

Indeterminate GlobeNewswire
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer
November 18, 2025

Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer

Indeterminate GlobeNewswire
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 18, 2025

Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights
November 18, 2025

NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights

Indeterminate GlobeNewswire
OKYO Pharma to Present at OIS XV in San Diego
November 18, 2025

OKYO Pharma to Present at OIS XV in San Diego

Indeterminate GlobeNewswire
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
November 18, 2025

Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference

Indeterminate GlobeNewswire
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
November 18, 2025

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

Indeterminate GlobeNewswire
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
November 18, 2025

Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference

Indeterminate GlobeNewswire
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
November 18, 2025

Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed

Indeterminate GlobeNewswire
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
November 18, 2025

INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

Indeterminate GlobeNewswire
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
November 18, 2025

MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference

Indeterminate GlobeNewswire
Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
November 18, 2025

Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Indeterminate GlobeNewswire
Ahead of Holiday Shopping, National Campaign Warns Consumers on Dangers of Counterfeit Cosmetics, Personal Care Products
November 18, 2025

Ahead of Holiday Shopping, National Campaign Warns Consumers on Dangers of Counterfeit Cosmetics, Personal Care Products

Indeterminate GlobeNewswire
Catheter Precision Announces Third VIVO Installation in France
November 18, 2025

Catheter Precision Announces Third VIVO Installation in France

Indeterminate GlobeNewswire
Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide
November 18, 2025

Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions